|
Q3 FY2024
As of Jan 31, 2024
|
Q2 FY2024
As of Oct 31, 2023
|
Q1 FY2024
As of Jul 31, 2023
|
Q4 FY2023
As of Apr 30, 2023
|
Q3 FY2023
As of Jan 31, 2023
|
Q2 FY2023
As of Oct 31, 2022
|
Q1 FY2023
As of Jul 31, 2022
|
Q4 FY2022
As of Apr 30, 2022
|
Q3 FY2022
As of Jan 31, 2022
|
Q2 FY2022
As of Oct 31, 2021
|
Q1 FY2022
As of Jul 31, 2021
|
Q4 FY2021
As of Apr 30, 2021
|
Q3 FY2021
As of Jan 31, 2021
|
Q2 FY2021
As of Oct 31, 2020
|
Q1 FY2021
As of Jul 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||||||||
| Accounts Receivable Fair Value Disclosure | |||||||||||||||
| Accounts receivable | |||||||||||||||
| Accounts receivable - related party | |||||||||||||||
| Short term loans receivable | |||||||||||||||
| Accounts receivable - related party from discontinued operations | |||||||||||||||
| Advance payments and prepaid expenses | |||||||||||||||
| Advance payments - related party | |||||||||||||||
| Inventories | |||||||||||||||
| TOTAL CURRENT ASSETS | |||||||||||||||
| Equipment, net depreciation | |||||||||||||||
| Construction in progress | |||||||||||||||
| Land and improvements | |||||||||||||||
| Long term prepaid expenses | |||||||||||||||
| Deferred assets | |||||||||||||||
| Security deposits | |||||||||||||||
| Stock | |||||||||||||||
| TOTAL NON-CURRENT ASSETS | |||||||||||||||
| TOTAL ASSETS | |||||||||||||||
| Accounts Payable and Accrued Liabilities, Current | |||||||||||||||
| Accrued expenses and other payables | |||||||||||||||
| Income tax payable | |||||||||||||||
| Due to related party | |||||||||||||||
| Advance receipts | |||||||||||||||
| Short term loans | |||||||||||||||
| Current portion of long term loans | |||||||||||||||
| Short term loans - related party | |||||||||||||||
| TOTAL CURRENT LIABILITIES | |||||||||||||||
| Loans | |||||||||||||||
| Loans - related party | |||||||||||||||
| Other long term liabilities | |||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||
| Preferred stock ($0.001 par value, 20,000,000 shares authorized, 0 issued and outstanding as of January 31, 2024 and April 30, 2023) | |||||||||||||||
| Common stock ($0.001 par value, 1,000,000,000 shares authorized, 437,592,510 and 502,562,280 shares issued and outstanding as of January 31, 2024 and April 30, 2023, respectively) | |||||||||||||||
| Common Stock Value | |||||||||||||||
| Non-controlling interest | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive income(loss) | |||||||||||||||
| Accumulated other comprehensive income(loss) from discontinued operations | |||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY(DEFICIT) | |||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY(DEFICIT) |
Loading...
